^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Biliary Tract Cancer |
| Drug: | 5-fluorouracil (Thymidylate synthase inhibitor) + irinotecan (Topoisomerase I inhibitor) + leucovorin calcium (Folate analog) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
03/29/2022
Excerpt:
Biliary Tract Cancers...Other recommended Regimens...Liposomal irinotecan + fluorouracil + leucovorin
